REG - Sealand Capital - Appointment of Chief Executive Officer

Sealand Capital GalaxyAnnouncement

20/01/2025 09:30

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250120:nRST9460Ta&default-theme=true

RNS Number : 9460T  Sealand Capital Galaxy Limited  20 January 2025

THE INFORMATION CONTAINED WITH IN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY
TO CONSTITUTE INSIDE INFORMATION AS STIPULATED UNDER THE MARKET ABUSE
REGULATION (EU) NO. 596/2014, AS AMENDED WHICH, BY VIRTUE OF THE EUROPEAN
UNION (WITHDRAWAL) ACT 2018, FORMS PART OF UK LAW. ON THE PUBLICATION OF THIS
ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE ("RIS"), THIS INSIDE
INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

 

20 January 2025

 

Sealand Capital Galaxy Limited

("Sealand" or the "Company")

 

APPOINTMENT OF CHIEF EXECUTIVE OFFICER

 

Sealand Capital Galaxy Limited [LSE: SCGL] ("Sealand" or the "Company"), an
IT, Social Media & Technology company focused on consolidating compelling
opportunities in the global marketplace, is pleased to announce the
appointment of Dr. Thomas Sawyer PhD, MBA as Chief Executive Officer of the
Company with immediate effect.

 

Following the appointment of Dr. Sawyer, PhD, MBA, Ms. Elena Suet Sum Law will
retire her role as Chief Executive Officer of the Company and maintain her
position as Chairwoman of the Board.

 

Dr. Thomas Sawyer PhD, MBA

 

Dr. Thomas Sawyer is an accomplished executive and thought leader with
extensive experience in biotechnology, medical technology, AI, and data-driven
innovation. With a proven track record of success at senior management and
board levels across public and private sectors, Dr. Sawyer specializes in
identifying high-potential technologies and driving business growth through
innovative strategies and partnerships.

 

Dr. Sawyer's expertise encompasses corporate strategy, financing, IPO
execution, and fostering collaborations across the technology, global
healthcare systems and biopharma sectors.

 

Dr. Sawyer holds a PhD in Life Sciences from the University of Glasgow and an
Executive MBA from the University of Cambridge. Over his career, he has served
in senior executive roles in both public and private companies, successfully
driving technological innovations and fostering partnerships across the UK,
EU, USA, and APAC regions. His academic affiliations include an honorary
lecturer at the University College London and mentorship at the Judge Business
School at the University of Cambridge.

 

Dr. Sawyer combines technical expertise and strategic vision to bridge the gap
between technology and business. His leadership philosophy emphasizes
adaptability, stakeholder alignment, and scalable solutions for complex
business challenges.

 

Appointed Chief Executive Officer, Dr. Tom Sawyer commented,

 

"It is an exciting time for Sealand, as the business looks to strategically
enhance existing operations and look to access scalable opportunities through
exploring new technological advances. I am committed and motivated in this new
role and look forward to working with the Sealand team in progressing the
Company and delivering value to our shareholders."

 

Chairwoman, Ms. Elena Suet Sum Law commented,

 

"The Board and I are delighted to welcome Dr. Sawyer as the Company's newly
appointed Chief Executive Officer. Dr. Sawyer provides the Company and our
shareholders an Executive with a truly rare, valuable and balanced skillset
that greatly compliments Sealands present and future ambitions."

 

Dr. Thomas Sawyer PhD, MBA (Chief Executive Officer)

 

Upon appointment, Dr Thomas Sawyer has been awarded 1,250,000 Stock Options.
The Stock Options granted have a strike price of £0.12, a life to expiry of
5-years from date of grant and vest upon 12-months of service.

 

Dr. Thomas Sawyer holds no ordinary shares in Sealand Capital Galaxy Limited.
Dr. Thomas Sawyer will not join the Board of Directors at this time but will
assume the role of CEO reporting to the Board.

 

CEO - Stockbox Introduction Interview

 

The Company are pleased to also provide a link 'here
(https://youtu.be/SAwMA626jqY) ' for a CEO introduction interview with the
Company's appointed PR/IR firm, Stockbox Media.

 

The information contained within this announcement is deemed by the Company to
constitute inside information as stipulated under the Market Abuse Regulation
(EU) No. 596/2014 as it forms part of United Kingdom domestic law by virtue of
the European Union (Withdrawal) Act 2018 (as amended).

 

 

-Ends-

 

 

Enquiries:

 

Sealand Capital Galaxy Limited

 

Dr. Thomas Sawyer (Chief Executive Officer)

Ms. Elena Suet Sum Law (Chairwoman)

Mr. Geoffrey Griggs (Non-Executive Director)

 

Bowsprit Partners Limited (Financial Adviser)
       +44 (0) 203 833 4430

 

Stockbox Media (PR/IR)

info@stockboxmedia.com (mailto:info@stockboxmedia.com)

 

 

Notes to Editors:

The Company's Shares are traded on the transition category of the London Stock
Exchange under the ticker LSE: SCGL

 

Further information on Sealand Capital Galaxy Limited is available on its
website http://scg-ltd.com (http://scg-ltd.com)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  UPDFIFLALLIIFIE